Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Breast Surgery

Treatment Options: From Monitoring to Removal

At a Glance

Most confirmed breast fibroadenomas can be safely monitored, but rapid growth, symptoms, atypia, or uncertainty may lead to removal. Options include vacuum-assisted excision, cryoablation for carefully selected lesions, and open surgery.

For most women with a confirmed fibroadenoma, the standard of care is not surgery, but observation [1][2]. Because these growths are benign and often stabilize or even shrink over time, doctors generally recommend intervention only when the lump causes symptoms, grows rapidly, or if there is any uncertainty about the diagnosis [1][3].

The Standard Approach: Observation

Observation pathways differ depending on whether you have had a biopsy.

  • Imaging-only BI-RADS 3 follow-up: For a BI-RADS 3 finding without a biopsy, observation commonly uses a 6-, 12-, and 24-month imaging pathway to ensure the mass is stable [4][5].
  • Biopsy-proven concordant fibroadenoma: If your clinical exam, imaging, and biopsy all agree that the lump is a simple fibroadenoma (a state called concordance), observation is a safe and effective path [1][6]. You may return to routine screening or receive individualized clinical and imaging follow-up depending on your age, size, symptoms, growth, and local protocol. Size alone is rarely a reason for surgery; many large fibroadenomas are perfectly harmless [2][3].

When Is Removal Recommended?

While observation is common, your doctor may recommend removal in the following “red flag” or symptomatic situations. Large or giant lesions require individualized review rather than a blanket rule.

  • Rapid Growth: If the lump grows significantly between checkups, removal is often advised to rule out a phyllodes tumor (a similar-looking growth that can grow faster) [1][7].
  • Atypia or Uncertainty: If a biopsy shows “atypical” cells or if the pathology and imaging don’t match (discordance), the tissue should be removed for a full examination [1][8].
  • Symptoms: Persistent pain, physical discomfort, or a lump that significantly changes the shape of the breast (asymmetry) are common reasons for removal [1][9].
  • Patient Preference: If the presence of the lump causes significant anxiety, you may choose to have it removed for peace of mind [7][3].

Minimally Invasive Options

For selected small to medium-sized fibroadenomas, minimally invasive procedures can remove or shrink the lump without traditional surgery [10][11]. These are not interchangeable or universally available options, and they usually require a confidently established diagnosis.

Vacuum-Assisted Excision (VAE)

In this outpatient procedure, a doctor uses a specialized needle and ultrasound guidance to vacuum out the fibroadenoma in pieces [11].

  • Benefits: It usually requires a smaller incision than open surgery, can be done under local anesthesia, and often costs less [12][11].
  • Risks & Limitations: Potential material risks include bruising, hematoma, pain, infection, skin or nipple injury, incomplete removal, and re-intervention. While many see total removal, there is a risk of leaving small pieces of tissue behind, which can lead to the lump “recurring” or appearing again on future scans [10][5]. Larger lumps have a higher risk of incomplete removal [13]. Results are study-dependent and not guaranteed.

Cryoablation

This technique uses extreme cold to freeze and destroy the fibroadenoma tissue [14].

  • Diagnostic Prerequisite: Because cryoablation destroys the lesion and does not provide a complete excision specimen for histologic examination, it should be limited to carefully selected lesions with an adequate benign core-biopsy diagnosis and radiologic-pathologic concordance; it is not an appropriate way to manage a cellular or indeterminate fibroepithelial lesion, atypia, discordance, or a possible phyllodes tumor.
  • What to expect: Unlike VAE, the lump isn’t removed immediately; instead, the intentionally treated tissue remains in place and gradually shrinks over several months [15][9]. Studies show varying volume reduction ranges.
  • Benefits & Risks: It avoids large incisions, but risks include a persistent palpable mass, bruising, skin injury, and the possibility of repeat treatment [9][14].

Open Surgical Excision

Traditional surgery involves an incision to remove the entire lump in one piece [14].

  • When it’s best: This is the preferred method for suspected phyllodes tumors, discordant results, or when a biopsy has shown concerning cellular changes [1][16]. It is also used for giant fibroadenomas.
  • The trade-off: While it provides the most definitive diagnosis by making tissue available for complete pathology and the lowest chance of the lump returning, it involves a larger scar and a longer recovery period than minimally invasive options [17][18].

Common questions in this guide

Can a breast fibroadenoma be safely watched instead of removed?
Yes. Observation is commonly recommended when the clinical examination, imaging, and biopsy agree that the lump is a fibroadenoma. If a probably benign BI-RADS 3 finding has not been biopsied, follow-up imaging is often performed at 6, 12, and 24 months, with the exact plan individualized.
When should a fibroadenoma be removed?
Removal may be advised if the lump grows rapidly, causes persistent pain or discomfort, changes the shape of the breast, or if the biopsy and imaging do not agree. Atypical cells, concern for a phyllodes tumor, or a very large lesion may also prompt individualized surgical review. Some patients choose removal because the lump causes significant anxiety.
What is vacuum-assisted excision for a breast fibroadenoma?
Vacuum-assisted excision is an outpatient procedure that uses a specialized needle and ultrasound guidance to remove a fibroadenoma in pieces, often with local anesthesia and a smaller incision than open surgery. Possible problems include bruising, bleeding into the tissue, pain, infection, incomplete removal, and the need for another procedure. Larger lumps are more likely to be incompletely removed.
Is cryoablation an option for every breast fibroadenoma?
No. Cryoablation is intended for carefully selected lesions with a needle biopsy confirming a benign fibroadenoma and agreement between the imaging and pathology findings. Because it destroys the tissue instead of removing it for complete examination, it is not appropriate when atypia, uncertain or discordant results, a cellular fibroepithelial lesion, or a possible phyllodes tumor is present; the treated lump remains in place and shrinks over months.
How does open excision compare with minimally invasive treatment?
Open surgical excision removes the entire lump in one piece and provides tissue for complete pathology, so it is preferred when a phyllodes tumor or concerning cellular changes cannot be ruled out. It usually causes a larger scar and requires a longer recovery than vacuum-assisted excision or cryoablation. It provides the most definitive examination and the lowest chance of the lump returning.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my 'triple assessment' results, is observation considered the standard of care for me right now?
  2. 2.If we choose observation, what is our specific plan for follow-up imaging, and what symptoms should I look for that would change this plan?
  3. 3.Am I a candidate for minimally invasive options like VAE or cryoablation, or is my fibroadenoma too large for those to be effective?
  4. 4.If I choose VAE, what are the chances that some of the tissue will be left behind or that the lump will grow back?
  5. 5.In my case, what are the specific benefits of open surgical excision compared to minimally invasive procedures?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?

    Lee A, James J, Whisker L, et al.

    Annals of the Royal College of Surgeons of England 2022; (104(5)):361-366 doi:10.1308/rcsann.2021.0208.

    PMID: 34939848
  2. 2

    Is excision biopsy of fibroadenomas based solely on size criteria warranted?

    Neville G, Neill CO, Murphy R, et al.

    The breast journal 2018; (24(6)):981-985 doi:10.1111/tbj.13069.

    PMID: 29802656
  3. 3

    Trends, Outcomes, and Costs of Surgical Excisional Biopsy for Fibroadenoma of the Breast.

    Rath P, Vasigh M, Soleimani T, Euhus DM

    World journal of surgery 2025; (49(4)):797-803 doi:10.1002/wjs.12542.

    PMID: 40059293
  4. 4

    Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.

    Berg WA, Berg JM, Sickles EA, et al.

    Radiology 2020; (296(1)):32-41 doi:10.1148/radiol.2020192641.

    PMID: 32427557
  5. 5

    Efficacy and safety of vacuum-assisted excision (VAE) of fibroadenomas: experience in a tertiary centre.

    Carriero S, Depretto C, Cozzi A, et al.

    La Radiologia medica 2023; (128(10)):1199-1205 doi:10.1007/s11547-023-01684-9.

    PMID: 37530965
  6. 6

    European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.

    Rubio IT, Wyld L, Marotti L, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2024; (50(1)):107292 doi:10.1016/j.ejso.2023.107292.

    PMID: 38061151
  7. 7

    Enlarging biopsy-proven fibroadenoma: Is surgical excision necessary?

    Dialani V, Chansakul T, Lai KC, et al.

    Clinical imaging 2019; (57()):35-39 doi:10.1016/j.clinimag.2019.03.014.

    PMID: 31103907
  8. 8

    Demystifying Breast Disease Markers.

    Wells VA, Medeiros I, Shevtsov A, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2023; (43(10)):e220151 doi:10.1148/rg.220151.

    PMID: 37676826
  9. 9

    Safety and Efficacy of Ultrasound-Guided Cryoablation for Benign Breast Fibroepithelial Lesions.

    Plaza MJ, Kumar AV, Sanchez-Gonzalez MA

    Journal of breast imaging 2019; (1(4)):324-328 doi:10.1093/jbi/wbz047.

    PMID: 38424801
  10. 10

    Ultrasound Guided Therapeutic Excisional Vacuum Assisted Biopsy in Breast Fibroadenomas.

    Buğdaycı O, Kaya H, Arıbal E

    The journal of breast health 2017; (13(2)):74-76 doi:10.5152/tjbh.2017.3038.

    PMID: 31244532
  11. 11

    Surgeon-Performed Vacuum-Assisted Biopsy of the Breast: Results from a Multicentre Australian Study.

    Bennett I, de Viana D, Law M, Saboo A

    World journal of surgery 2020; (44(3)):819-824 doi:10.1007/s00268-019-05266-7.

    PMID: 31712841
  12. 12

    Patient experience and healthcare cost aspects of vacuum-assisted excision of breast lesions. A report from the Swedish VAE randomized clinical trial.

    Zouzos A, Fredriksson I, Karakatsanis A, et al.

    European journal of radiology 2025; (186()):112062 doi:10.1016/j.ejrad.2025.112062.

    PMID: 40127593
  13. 13

    Minimally Invasive Breast Fibroadenoma Excision Using an Ultrasound-Guided Vacuum-Assisted Biopsy Device.

    Papathemelis T, Heim S, Lux MP, et al.

    Geburtshilfe und Frauenheilkunde 2017; (77(2)):176-181 doi:10.1055/s-0043-100387.

    PMID: 28331240
  14. 14

    Breast cryoablation for management of benign fibroadenomas: A systematic review of the literature.

    Ramgopal Y, Dodelzon K, Coffey K, Lamparello NA

    Clinical imaging 2025; (127()):110632 doi:10.1016/j.clinimag.2025.110632.

    PMID: 41061430
  15. 15

    Ultrasound-guided cryoablation: Our experience in percutaneous treatment as an alternative to surgery for fibroadenomas of the breast lesions.

    Díaz de Bustamante Durbán T, Roca Navarro MJ, Navarro Monforte Y, et al.

    Radiologia 2024; (66(3)):228-235 doi:10.1016/j.rxeng.2022.12.011.

    PMID: 38908884
  16. 16

    Giant Juvenile Fibroadenoma: Case Report and Review of the Literature.

    Eleftheriades A, Tsarna E, Toutoudaki K, et al.

    Journal of clinical medicine 2023; (12(5)) doi:10.3390/jcm12051855.

    PMID: 36902642
  17. 17

    Effectiveness of ultrasound-guided vacuum-assisted excision for treating benign breast lesions.

    Tan X, Xuhong J, Ai X, et al.

    Cancer innovation 2025; (4(1)):e158 doi:10.1002/cai2.158.

    PMID: 39544723
  18. 18

    Intermediate and long-term outcomes of fibroadenoma excision in adolescent and young adult patients.

    Javed A, Jenkins SM, Labow B, et al.

    The breast journal 2019; (25(1)):91-95 doi:10.1111/tbj.13159.

    PMID: 30444280

This page explains breast fibroadenoma treatment options for informational purposes only and does not constitute medical advice. Your breast specialist can help you compare monitoring, minimally invasive treatment, and surgery.

Get notified when new evidence is published on breast fibroadenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.